Figure S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
crossref（2023）
摘要
Volume curves for all patients integrating pre and under treatment 3D volume data by central review. *patients with drugs intake < 2 months ** pre/post operative MRI non-available
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要